Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03744871 · ClinicalTrials.gov registry record · NA
Air Pollution: Strategies for Personalized Intervention to Reduce Exposure
A NA study of Air Pollution, sponsored by University Hospitals Cleveland Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 2
- Study locations
NCT03744871: Completed NA study of Air Pollution, sponsored by University Hospitals Cleveland Medical Center.
NCT03744871 is a NA study of Air Pollution that has completed, run by University Hospitals Cleveland Medical Center. The registered enrollment target is 30 participants, below the 58-participant average among 7 other Air Pollution trials with a reported enrollment target (48% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03744871, a NA study of Air Pollution, has completed, sponsored by University Hospitals Cleveland Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 2
- Study locations
Study Summary
Fine particulate matter \< 2.5 microns (PM2.5) air pollution is a leading global risk factor for cardiovascular morbidity and mortality. PM2.5 presents a serious ongoing public health threat to patients living in highly-polluted countries (ex: China, India) where air quality is projected to remain extremely poor (far exceeding World Health Organization Air Quality Guidelines) for the foreseeable future. This study reviews the benefits of personal level intervention (wearing N95 respirator) over long term, to prevent clinical events among patients with cardiovascular disease.
Primary Outcome
Use Omron 907xl for clinic BP Measures, with 3 repeated measurements after 5 minutes after clinicians leave room (patient unattended). Averages of the 3 BP Recordings will be obtained
Conditions Studied
Interventions
- OTHER N95 Respirator
Study Locations (2)
Ohio
- University Hospitals Cleveland Medical Center - Cleveland
Other
- Peking University - Beijing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2019-03-22 |
| Est. Completion | 2023-07-31 |
| Phase | NA |
What the finished NCT03744871 record still lists
NCT03744871 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 58-participant average among 7 other Air Pollution trials with a reported enrollment target (48% lower).
The record links to 1 condition, with Air Pollution appearing as the primary indexed condition, and to 1 intervention - of which N95 Respirator is the first listed.
NCT03744871 reports a single indexed study location in Ohio, Other.
Frequently Asked Questions
What is clinical trial NCT03744871 about?
NCT03744871 is a clinical study titled "Air Pollution: Strategies for Personalized Intervention to Reduce Exposure". Fine particulate matter \< 2.5 microns (PM2.5) air pollution is a leading global risk factor for cardiovascular morbidity and mortality. PM2.5 presents a serious ongoing public health threat to patients living in highly-polluted countries (ex: China, India) where air quality is projected to remain e...
What is the current status of trial NCT03744871?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2019-03-22. Estimated completion is 2023-07-31.
What conditions does trial NCT03744871 study?
This clinical trial studies the following conditions: Air Pollution.
What interventions are being tested in trial NCT03744871?
The interventions under investigation include: N95 Respirator (OTHER).
Who is sponsoring clinical trial NCT03744871?
This trial is sponsored by University Hospitals Cleveland Medical Center, which has 230 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03744871 being conducted?
This trial has 2 study locations across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Air Pollution
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
HEPA, PM2.5, and Cardiometabolic Health
RECRUITING · NA
-
The Role of Macrophage Activation in Lung Injury Following Ozone Exposure
RECRUITING · NA
-
Using Indoor Air Filtration to Slow Atherothrombosis Progression in Adults With Ischemic Heart Disease History
RECRUITING · NA
-
Does Sildenafil Increase Exercise Performance in Air Pollution?
COMPLETED · NA
-
Particulate Matter, Blood Pressure, and the Sympathetic Nervous System
COMPLETED · NA
-
Boston Puerto Rican Health Study
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI